-
Je něco špatně v tomto záznamu ?
Poor chemical and microbiological quality of the commercial milk thistle-based dietary supplements may account for their reported unsatisfactory and non-reproducible clinical outcomes
M. Fenclova, A. Novakova, J. Viktorova, P. Jonatova, Z. Dzuman, T. Ruml, V. Kren, J. Hajslova, L. Vitek, M. Stranska-Zachariasova,
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NV16-27317A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
NLK
Directory of Open Access Journals
od 2011
Free Medical Journals
od 2011
Nature Open Access
od 2011-12-01
PubMed Central
od 2011
Europe PubMed Central
od 2011
ProQuest Central
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Health & Medicine (ProQuest)
od 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2011
Springer Nature OA/Free Journals
od 2011-12-01
- MeSH
- antioxidancia chemie fyziologie MeSH
- biologické přípravky chemie farmakologie MeSH
- fytoterapie metody MeSH
- lidé MeSH
- mykotoxiny chemie MeSH
- nemoci jater farmakoterapie MeSH
- ostropestřec mariánský chemie mikrobiologie MeSH
- pesticidy chemie MeSH
- potravní doplňky mikrobiologie MeSH
- rostlinné extrakty chemie farmakologie MeSH
- silymarin chemie farmakologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Herbal-based dietary supplements have become increasingly popular. The extract from milk thistle (Silybum marianum), is often used for the treatment of liver diseases. However, serious concerns exist regarding the efficacy, composition, as well as the safety of these over-the-counter preparations. Therefore, the aim of the present study was to investigate the composition as well as chemical and biological safety of 26 milk thistle-based dietary supplements purchased from both the U.S. and Czech markets between 2016 and 2017. The study was focused on a determination of the composition of active ingredients, as well as analyses of possible contaminants including: mycotoxins, plant alkaloids, and pesticide residues, as well as the microbial purity. High-throughput analyses were performed using advanced U-HPLC-HRMS techniques. Large differences in the silymarin content were observed among individual milk thistle preparations, often in contrast with the information provided by the manufacturers. In addition, substantial inter-batch differences in silymarin content were also demonstrated. In all milk thistle preparations tested, large numbers and high concentrations of mycotoxins and several pesticides, as well as the substantial presence of microbiological contamination were detected, pointing to serious safety issues. In conclusion, our results strongly indicate the need for strict controls of the composition, chemical contaminants, as well as the microbiological purity of commercial milk thistle extracts used for the treatment of liver diseases. Poor definition of these preparations together with contamination by biologically active substances may not only account for the inconsistency of clinical observations, but also be responsible for possible herbal-based dietary supplements-induced liver injury.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20028866
- 003
- CZ-PrNML
- 005
- 20210114155237.0
- 007
- ta
- 008
- 210105s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41598-019-47250-0 $2 doi
- 035 __
- $a (PubMed)31366891
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Fenclova, Marie $u Department of Food Analysis and Nutrition, University of Chemistry and Technology, Technicka 3, 16628, Prague 6, Czech Republic.
- 245 10
- $a Poor chemical and microbiological quality of the commercial milk thistle-based dietary supplements may account for their reported unsatisfactory and non-reproducible clinical outcomes / $c M. Fenclova, A. Novakova, J. Viktorova, P. Jonatova, Z. Dzuman, T. Ruml, V. Kren, J. Hajslova, L. Vitek, M. Stranska-Zachariasova,
- 520 9_
- $a Herbal-based dietary supplements have become increasingly popular. The extract from milk thistle (Silybum marianum), is often used for the treatment of liver diseases. However, serious concerns exist regarding the efficacy, composition, as well as the safety of these over-the-counter preparations. Therefore, the aim of the present study was to investigate the composition as well as chemical and biological safety of 26 milk thistle-based dietary supplements purchased from both the U.S. and Czech markets between 2016 and 2017. The study was focused on a determination of the composition of active ingredients, as well as analyses of possible contaminants including: mycotoxins, plant alkaloids, and pesticide residues, as well as the microbial purity. High-throughput analyses were performed using advanced U-HPLC-HRMS techniques. Large differences in the silymarin content were observed among individual milk thistle preparations, often in contrast with the information provided by the manufacturers. In addition, substantial inter-batch differences in silymarin content were also demonstrated. In all milk thistle preparations tested, large numbers and high concentrations of mycotoxins and several pesticides, as well as the substantial presence of microbiological contamination were detected, pointing to serious safety issues. In conclusion, our results strongly indicate the need for strict controls of the composition, chemical contaminants, as well as the microbiological purity of commercial milk thistle extracts used for the treatment of liver diseases. Poor definition of these preparations together with contamination by biologically active substances may not only account for the inconsistency of clinical observations, but also be responsible for possible herbal-based dietary supplements-induced liver injury.
- 650 _2
- $a antioxidancia $x chemie $x fyziologie $7 D000975
- 650 _2
- $a biologické přípravky $x chemie $x farmakologie $7 D001688
- 650 _2
- $a potravní doplňky $x mikrobiologie $7 D019587
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nemoci jater $x farmakoterapie $7 D008107
- 650 _2
- $a ostropestřec mariánský $x chemie $x mikrobiologie $7 D020944
- 650 _2
- $a mykotoxiny $x chemie $7 D009183
- 650 _2
- $a pesticidy $x chemie $7 D010575
- 650 _2
- $a fytoterapie $x metody $7 D008517
- 650 _2
- $a rostlinné extrakty $x chemie $x farmakologie $7 D010936
- 650 _2
- $a silymarin $x chemie $x farmakologie $7 D012838
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Novakova, Alena $u Department of Food Analysis and Nutrition, University of Chemistry and Technology, Technicka 3, 16628, Prague 6, Czech Republic.
- 700 1_
- $a Viktorova, Jitka $u Department of Biochemistry and Microbiology, University of Chemistry and Technology, Technicka 3, 16628, Prague 6, Czech Republic.
- 700 1_
- $a Jonatova, Petra $u Department of Food Analysis and Nutrition, University of Chemistry and Technology, Technicka 3, 16628, Prague 6, Czech Republic.
- 700 1_
- $a Dzuman, Zbynek $u Department of Food Analysis and Nutrition, University of Chemistry and Technology, Technicka 3, 16628, Prague 6, Czech Republic.
- 700 1_
- $a Ruml, Tomas $u Department of Biochemistry and Microbiology, University of Chemistry and Technology, Technicka 3, 16628, Prague 6, Czech Republic.
- 700 1_
- $a Kren, Vladimir $u Laboratory of Biotransformation, Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1082, 14000, Prague 6, Czech Republic.
- 700 1_
- $a Hajslova, Jana $u Department of Food Analysis and Nutrition, University of Chemistry and Technology, Technicka 3, 16628, Prague 6, Czech Republic.
- 700 1_
- $a Vitek, Libor $u Institute of Medical Biochemistry and Laboratory Diagnostics and 4th Department of Internal Medicine, 1st Faculty of Medicine, Charles University, Katerinska 32, 12108, Prague 2, Czech Republic. vitek@cesnet.cz.
- 700 1_
- $a Stranska-Zachariasova, Milena $u Department of Food Analysis and Nutrition, University of Chemistry and Technology, Technicka 3, 16628, Prague 6, Czech Republic. milena.stranska@vscht.cz.
- 773 0_
- $w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 9, č. 1 (2019), s. 11118
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31366891 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20210114155235 $b ABA008
- 999 __
- $a ok $b bmc $g 1609201 $s 1120046
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 9 $c 1 $d 11118 $e 20190731 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
- GRA __
- $a NV16-27317A $p MZ0
- LZP __
- $a Pubmed-20210105